Healthcare - Biotechnology - NASDAQ - US
$ 0.295
-1.57 %
$ 9.9 M
Market Cap
-0.28
P/E
INCOME STATEMENT
0
REVENUE
-42.6 M
OPERATING INCOME
-40.2 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Vincerx Pharma, Inc.
| Revenue | 0 |
| Cost Of Revenue | 915 K |
| Gross Profit | -915 K |
| Operating Expenses | 42.6 M |
| Operating Income | -42.6 M |
| Other Expenses | -2.45 M |
| Net Income | -40.2 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.9 | 0.9 | 0.3 | 0.2 | 0.2 |
| Gross Profit | (0.9) | (0.9) | (0.3) | (0.2) | (0.2) |
| OPERATING INCOME | |||||
| Operating Expenses | 42.6 | 71.1 | 62.7 | 10.7 | 45 K |
| Selling, General and Administrative Expenses | 13.6 | 19.0 | 22.6 | 3.6 | 45 K |
| Research and Development Expenses | 29.0 | 52.2 | 40.1 | 7.1 | 0 |
| Operating Income | (42.6) | (73.6) | (62.7) | (10.7) | 45 K |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | (8.2) | 0 | 8 K | 0 |
| Total Other Income | 2.5 | 8.2 | 23.4 | (5.9) | 0 |
| Pre-Tax Income | (40.2) | (65.4) | (39.3) | (10.7) | 45 K |
| NET INCOME | |||||
| Tax Provision | 0 | (8.2) | (23.7) | 8 K | 54 |
| Net Income | (40.2) | (57.2) | (15.6) | (10.7) | 45 K |
| EPS | 1.89 | 2.72 | 0.91 | 0.77 | 0.0087 |